BIOPATTERN Trial
Coronary Artery Disease (Endotyping)
N/A (Clinical Research Trial)Active
Key Facts
Indication
Coronary Artery Disease (Endotyping)
Phase
N/A (Clinical Research Trial)
Status
Active
Company
About PlaqueTec
PlaqueTec is a private, pre-revenue diagnostics company founded in 2014 in Cambridge, UK, focused on endotyping Coronary Artery Disease. Its core innovation is a novel catheter-based Liquid Biopsy System that captures trans-plaque biomarker gradients during coronary angiography, generating unique biological data from the site of disease. The company is currently running the BIOPATTERN trial to build a biomarker database from 300 CAD patients, aiming to identify new drug targets and enable stratified clinical trials for pharmaceutical partners. PlaqueTec's approach seeks to move CAD treatment from a one-size-fits-all model to a precision medicine paradigm.
View full company profile